Navigation Links
China Probiotics Market 2012-2016
Date:3/11/2013

DUBLIN, March 11, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "China Probiotics Market 2012-2016" market research report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

China only started to research and develop, mass produce and consume probiotics in the 1990s - much later than that in Japan and Europe. But the Chinese probiotics market has been increasing at a high rate due to the fast-growing yoghurt, supplement, pharma and feed sectors over the past decade. This research report gives an in-depth analysis of what comprises the ¥33,055 milllion ($5,117 million) China probiotics market size in 2011 and how the future market size will grow over the next 5 years.

There are several hundred kinds of nutritional foods and ingredients containing probiotics currently sold in the Chinese market, such as fermented milk (yoghurt), fermented cheese or cream, fermented soy milk, probiotics supplement and pharma products. This report will also give the detailed information on the typical products on the market in China.

Key players in the China probiotics market are comprehensively assessed in this report, in terms of corporate share structure, historical business achievement, product categories, product quality and prices, state of technological process development, competitive landscape - including foreign and domestic competitors, etc.

This research report also addresses the top concerns of overseas probiotics companies in the Chinese market:

- How competitive are the Chinese companies, especially China-Biotics, compared to the foreign ones?

- How real is the thre
'/>"/>

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. China Market Data: Acrylonitrile, Phytol and Branched Chain Amino Acids Analysis in New Research Reports at RnRMarketResearch.com
2. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
3. China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
4. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
5. Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
6. Lucintel’s Analysis of Growth Opportunities in China’s Composites Industry: Expect Market to Surpass $11 Billion in 2017
7. China Cord Blood Corporation to Further Consolidate its Corporate Structure
8. Biomaterials China News 1210 - Annual Subscription
9. China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013
10. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
11. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 The new Public-Private Partnership (PPP) ... the association’s recent annual meeting drew praise from community ... Kroes, who called the action “a huge step forward ... to European innovation.” , The Board of Stakeholders voted ... Photonics PPP at its 29 April meeting in Brussels, ...
(Date:5/17/2013)... International, Inc. (NASDAQ: YONG ) ("Yongye" or ... crop nutrient products in the People,s Republic ... 16, 2013, the special committee (the "Special Committee") of ... provided a letter (the "Letter") issued by Abax Global ... to Full Alliance International Limited ("Full Alliance"). The Letter, ...
(Date:5/17/2013)... 17, 2013 The paradigm of ‘one ... systems that can help predict the adverse and therapeutic ... Stepaniants, Head of Computational Biology at the Genomics Laboratory, ... to ensure high-quality genomics when used as part of ... to complex data sets to identify key clinical targets ...
(Date:5/17/2013)... Tooth decay is an epidemic in American children with 50% ... World Health Organization says that worldwide, 60–90% of ... are the long-term effects of this transmissible infection? , ... oral bacterial imbalance and serious systemic issues like heart disease. ... also 100% preventable? Answer: there has been no way to ...
Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... Milestones, CRANBURY, N.J., Nov. 3 Amicus Therapeutics,(Nasdaq: ... third quarter of,2008. On a reported basis calculated in ... a net loss,attributable to common stockholders of $0.36 per ... three months ended September 30, 2008. As of,September 30, ...
... Nov. 3 Biomoda, Inc. (OTC,Bulletin Board: BMOD) ... announced today that BUYINS.NET, http://www.buyins.net, is initiating ... data to October 2008. From November 2006 to ... BMOD have traded,for a total dollar value of ...
... and GUELPH, Ontario, Nov. 3 LI-COR,Biosciences ... agreement to,distribute LI-COR biotechnology products in Canada ... local presence of Mandel Scientific skilled staff, ... enhance our ability to serve,our Canadian customers," ...
Cached Biology Technology:Amicus Therapeutics Announces Third Quarter 2008 Financial Results 2Amicus Therapeutics Announces Third Quarter 2008 Financial Results 3Amicus Therapeutics Announces Third Quarter 2008 Financial Results 4Amicus Therapeutics Announces Third Quarter 2008 Financial Results 5Amicus Therapeutics Announces Third Quarter 2008 Financial Results 6Amicus Therapeutics Announces Third Quarter 2008 Financial Results 7Amicus Therapeutics Announces Third Quarter 2008 Financial Results 8Amicus Therapeutics Announces Third Quarter 2008 Financial Results 9Amicus Therapeutics Announces Third Quarter 2008 Financial Results 10Amicus Therapeutics Announces Third Quarter 2008 Financial Results 11Biomoda, Inc. (BMOD) SqueezeTrigger Price is $0.27. Approximately 1 Million Shares Shorted Since November 2006 According to Buyins.net Research Report 2Biomoda, Inc. (BMOD) SqueezeTrigger Price is $0.27. Approximately 1 Million Shares Shorted Since November 2006 According to Buyins.net Research Report 3Biomoda, Inc. (BMOD) SqueezeTrigger Price is $0.27. Approximately 1 Million Shares Shorted Since November 2006 According to Buyins.net Research Report 4LI-COR Biosciences and Mandel Scientific Company Inc. Announce Distribution Agreement 2
(Date:5/17/2013)... The AGA Research Foundation announced a new grant ... the gut microbiota, one of today,s most exciting areas ... The AGA Research Awards Panel selected Andrew T. Chan, ... and Harvard Medical School, Boston, as the 2013 AGA-Elsevier ... receive $25,000 of funding, commencing in July 2013, to ...
(Date:5/17/2013)... May 17, 2013, Shenzhen, China---- Why Tibetan antelope ... Qinghai-Tibetan Plateau? In a collaborative research published in ... BGI, and other institutes provide evidence that some ... adaption to harsh highland environments. The data in ... specific genetic mechanisms and the biology of other ...
(Date:5/16/2013)... a commitment to the support of underrepresented minority ... Foundation has announced the inaugural AGA Investing in ... by the National Institute of Diabetes and Digestive ... underrepresented minority students to further their research careers ... establishing this new award, AGA demonstrates its commitment ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... at Schepens Eye Research Institute, an affiliate of Harvard ... inside blood vessel cells that controls angiogenesis (new blood ... and off by the balance between two enzymes (known ... of the same lipid membrane to fulfill opposite missions, ...
... Institutes of Health today provided the clearest picture yet of ... genes associated with an increased risk of breast cancer. The ... 2 (BRCA2). In addition, the study identified key predictors for ... mutations. , Each year, approximately 200,000 women in the ...
... a Saint Louis University vaccine researcher scrutinizes what in ... available anthrax vaccine. , This new type of anthrax ... according to peer-reviewed research published in Vaccine . ... given to 100 volunteers at four sites around the ...
Cached Biology News:Schepens scientists are first to discover angiogenesis switch inside blood vessel cells 2Schepens scientists are first to discover angiogenesis switch inside blood vessel cells 3New findings offer more complete view of breast cancer gene mutations in US population 2New findings offer more complete view of breast cancer gene mutations in US population 3
... Thermo's orbital shaker stands ... a more ergonomic height, and ... Purpose-built from welded tubular steel, ... to support the weight and ...
... 5'G AATTC3' 3'CTTAA G5' Inactivation Conditions: Heat inactivation ... Storage Conditions: 10mM Tris-HCl (pH 7.5), 100mM KCl, ... BSA, 50% glycerol. Shipping and Storage: Shipped on ... unit is defined as the amount of enzyme ...
... experiment based analysis package designed with easy ... and powerful functionality., Image acquisition interface is ... easy image capture. Sequential and dynamic ... Saturation Warning Single ...
... stainless-steel shaker flask clips, purpose-designed to firmly ... All clips are equipped with a top ... include a bottom retainer spring, and silicon ... expensive glassware. Clips include the required ...
Biology Products: